New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 16, 2014
22:03 EDTCVSCVS Caremark shares could reach $85 in a year, Barron's says
CVS Caremark's move to stop selling tobacco products should bring in healthcare contract renewals, which more than make up for the EPS loss from tobacco sales. The stock could rise to $85 in a year, Barron's argues in a feature article. The company has a healthy dividend yield and buyback program, the paper adds. Reference Link
News For CVS From The Last 14 Days
Check below for free stories on CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
08:31 EDTCVSCVS Caremark's Accordant Health receives NCQA accreditation
CVS Caremark announced that its Accordant Health Services division has received full NCQA Patient and Practitioner Oriented Disease Management accreditation for programs to support: Epilepsy, Rheumatoid Arthritis, Multiple Sclerosis, Crohn's Disease, Ulcerative Colitis, Parkinson's Disease, Systemic Lupus Erythematosus, Myasthenia Gravis, Sickle Cell Disease, Cystic Fibrosis, Hemophilia, Scleroderma, Polymyositis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Amyotrophic Lateral Sclerosis, Dermatomyositis, and Gaucher Disease.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use